Advertisement
Advertisement
U.S. markets open in 8 hours 55 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Cannara Biotech Inc. (LOVFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.10180.0000 (0.00%)
At close: 11:56AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1018
Open0.0960
BidN/A x N/A
AskN/A x N/A
Day's Range0.1018 - 0.1018
52 Week Range0.0613 - 0.1916
Volume70,000
Avg. Volume22,236
Market Cap94.188M
Beta (5Y Monthly)1.84
PE Ratio (TTM)101.80
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for LOVFF

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CANNARA BIOTECH INC
    Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverThis edition features European banks; California utilities; traditional payment firms; and notes from Johnson & Johnson, Green Thumb Industries, and new coverage Lithium Americas.
    Rating
    Fair Value
    Economic Moat
    2 months agoMorningstar
View more
  • CNW Group

    Cannara Biotech Inc. Reports Fiscal First Quarter 2022 Financial Results

    Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced its fiscal first quarter of 2022 financial and operating results for the three-month period ended November 30, 2021.

  • PR Newswire

    Cannara Biotech Inc. to Webcast Live at VirtualInvestorConferences.com on January 20, 2022

    Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced that Nicholas Sosiak, Chief Financial Officer will present live at VirtualInvestorConferences.com on January 20th, 2022.

  • CNW Group

    Cannara Biotech Inc. Reports Fourth Quarter and Fiscal Year 2021 Results

    Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega cultivation facilities based in Québec spanning over 1,650,000 sq. ft., today announced its fourth quarter and fiscal year 2021 financial and operating results for the three and twelve-month periods ended August 31, 2021.

Advertisement
Advertisement